Company
Spruce Biosciences
Spruce is dedicated to developing and commercializing novel therapies for neurological disorders with significant unmet medical need.
Also known as SPRUCE BIOSCIENCES, INC.
- Status
- Operatingas of 2026-09-17Source (opens in a new tab)
- Business model
- B2B
- Headquarters
- South San Francisco, California, United States
- Legal name
- SPRUCE BIOSCIENCES, INC.
- sprucebiosciences.com (opens in a new tab)
- LinkedIn (opens in a new tab)
- X (opens in a new tab)
- Press page (opens in a new tab)
- Careers (opens in a new tab)
Claim, correct or request removal
Record updated 28 September 2026
About
Our mission at Spruce is to advance targeted, first-in-class therapies that address serious, underserved neurological conditions.
Funding snapshot
- Total raised
- $192MSEC form D sum, as of 2026-09-28Source (opens in a new tab)
- Latest round
- Round, $50M2025-10-09
Funding rounds
- Round, 2025
- $50M2025-10-09, SEC form D sold, 21 investors
- Round, 2023
- $53.6M2023-02-16, SEC form D sold, 20 investors
- Round, 2020
- $88M2020-02-19, SEC form D sold, 11 investors
Products
- Other
- TA-ERT
Loading relationship preview